article thumbnail

Redefining Acceleration of the Drug Development Journey

PPD

According to the United Nation’s 2024 World Population Prospects data, the global population of those 65 years old and over will grow from 0.8 From an aging population increasing health care demand to urgent, unmet medical needs, there are clear drivers to advance safe and effective medicines to patients faster than ever. billion in 2035.

article thumbnail

A Visual Guide to Genome Editors

Codon

pyogenes protein — whose compactness makes them far easier to package into viral vectors and deliver into the human body. Therapeutics The first Cas13-based clinical trial was approved in 2024. It was first characterized by Patrick Hsu’s lab at the Arc Institute in 2024.

DNA 81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Edwin Cohn and the Harvard Blood Factory

Codon

A package containing 100 cc. The soldiers stuffed their pockets with the small packages of albumin and administered it to many seriously wounded men, most of whom lived to be evacuated to ships and receive further medical care. ” Asimov Press (2024). cans of serum albumin. Cite: Gilliam, Eric.

article thumbnail

Levers for Biological Progress

Codon

They engineered genetically-encoded RNA exporters, based on viruses, that package and secrete RNA molecules in protective nanoparticles, allowing non-destructive monitoring of those RNA molecules in real-time. A complete neuronal wiring diagram of a fruit fly brain, consisting of about 140,000 neurons, was published in October 2024.

DNA 132
article thumbnail

Lexeo to help launch spinout around RNA drugs for the heart

BioPharma Drive: Drug Pricing

4, 2024 Permission granted by Bristol Myers Squibb Deep Dive // Brain drug revival Psychiatry drugs finally have pharma’s attention. 4, 2024 Permission granted by Bristol Myers Squibb Deep Dive // Brain drug revival Psychiatry drugs finally have pharma’s attention. By Jonathan Gardner • Sept. Can they keep it? Can they keep it?

RNA 219
article thumbnail

Private equity firms back PCI Pharma in bet on drug production

BioPharma Drive: Drug Pricing

PCI helps biopharmaceutical companies manufacture and package drug products used in clinical trials as well as commercially. 4, 2024 Keep up with the story. That funding was supported by a “significant reinvestment” from current backer Mubadala Investment Co. By Jonathan Gardner • Sept. By Jonathan Gardner • Sept.

article thumbnail

FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What Questions Did They Answer? (Part 1)

FDA Law Blog: Drug Discovery

Valentine On November 19, 2024, FDA released a draft guidance titled Frequently Asked Questions Developing Potential Cellular and Gene Therapy Products. The draft guidance recommends that no more than 15 questions are included in the briefing package. CBER will not commit to reviewing packages greater than 250 pages.